408
Participants
Start Date
April 21, 2017
Primary Completion Date
August 26, 2020
Study Completion Date
August 26, 2020
Dupilumab
"Pharmaceutical form: Solution~Route of administration: Subcutaneous"
Placebo
"Pharmaceutical form: Solution~Route of administration: Subcutaneous"
Asthma Controller Therapies
"Pharmaceutical form: Aerosol, capsules, tablets, oral solution~Route of administration: Inhaled, oral"
Asthma Reliever Therapies
"Pharmaceutical form: Nebulized, aerosol~Route of administration: Inhaled"
Investigational Site Number 348006, Budapest
Investigational Site Number 348003, Töröbálint
Investigational Site Number 036001, Campbelltown
Investigational Site Number 036003, Parkville/Melbourne
Investigational Site Number 348012, Mezőkövesd
Investigational Site Number 036002, South Brisbane
Investigational Site Number 036005, North Adelaide
Investigational Site Number 032006, Mendoza
Investigational Site Number 348002, Gyula
Investigational Site Number 348005, Szeged
Investigational Site Number 710004, Cape Town
Investigational Site Number 710001, Cape Town
Investigational Site Number 348008, Szigetvár
Investigational Site Number 348001, Székesfehérvár
Investigational Site Number 348007, Zalaegerszeg
Investigational Site Number 840013, New York
Investigational Site Number 840023, Great Neck
Investigational Site Number 840007, Rochester
Investigational Site Number 724002, Santiago de Compostela
Investigational Site Number 840021, Durham
Investigational Site Number 724005, Pozuelo de Alarcón
Investigational Site Number 840004, Charlotte
Investigational Site Number 484006, Chihuahua City
Investigational Site Number 484004, Chihuahua City
Investigational Site Number 484003, Durango
Investigational Site Number 380004, Padua
Investigational Site Number 840031, Birmingham
Investigational Site Number 380001, Verona
Investigational Site Number 840036, Owensboro
Investigational Site Number 840008, Cincinnati
Investigational Site Number 724003, Valencia
Investigational Site Number 840016, Ann Arbor
Investigational Site Number 804004, Dnipro
Investigational Site Number 804008, Kryvyi Rig
Investigational Site Number 380003, Florence
Investigational Site Number 840018, La Crosse
Investigational Site Number 804007, Chernivtsi
Investigational Site Number 804005, Kharkiv
Investigational Site Number 484001, Monterrey
Investigational Site Number 840022, Lincoln
Investigational Site Number 804002, Zaporizhzhya
Investigational Site Number 804003, Zaporizhzhya
Investigational Site Number 840024, Edmond
Investigational Site Number 804011, Ivano-Frankivsk
Investigational Site Number 840003, San Antonio
Investigational Site Number 840002, Gilbert
Investigational Site Number 840001, Rolling Hills Estates
Investigational Site Number 484002, Veracruz
Investigational Site Number 380007, Catania
Investigational Site Number 643006, Moscow
Investigational Site Number 643005, Saint Petersburg
Investigational Site Number 643002, Saint Petersburg
Investigational Site Number 643001, Saint Petersburg
Investigational Site Number 643003, Saint Petersburg
Investigational Site Number 643004, Perm
Investigational Site Number 170002, Santiago de Cali
Investigational Site Number 152007, Viña del Mar
Investigational Site Number 152002, Viña del Mar
Investigational Site Number 152003, Santiago
Investigational Site Number 152009, Santiago
Investigational Site Number 840012, Tucson
Investigational Site Number 840006, St Louis
Investigational Site Number 840035, New York
Investigational Site Number 032004, Buenos Aires
Investigational Site Number 032003, Buenos Aires
Investigational Site Number 032002, Caba
Investigational Site Number 032001, Caba
Investigational Site Number 076008, Blumenau
Investigational Site Number 076001, Porto Alegre
Investigational Site Number 076007, Porto Alegre
Investigational Site Number 076003, São Paulo
Investigational Site Number 076002, São Paulo
Investigational Site Number 076004, São Paulo
Investigational Site Number 076006, Sorocaba
Investigational Site Number 124004, Edmonton
Investigational Site Number 124002, Hamilton
Investigational Site Number 124001, Montreal
Investigational Site Number 124003, Québec
Investigational Site Number 152005, Santiago
Investigational Site Number 152001, Valdivia
Investigational Site Number 792005, Adana
Investigational Site Number 792001, Ankara
Investigational Site Number 792006, Bursa
Investigational Site Number 792003, Istanbul
Investigational Site Number 792004, Istanbul
Investigational Site Number 170004, Antioquia
Investigational Site Number 380005, Roma
Investigational Site Number 440002, Kaunas
Investigational Site Number 440005, Šiauliai
Investigational Site Number 440003, Utena
Investigational Site Number 440001, Vilnius
Investigational Site Number 440004, Vilnius
Investigational Site Number 616001, Lodz
Investigational Site Number 616002, Poznan
Investigational Site Number 642001, Bucharest
Investigational Site Number 724001, Barcelona
Investigational Site Number 724006, Esplugues de Llobregat
Investigational Site Number 792008, Ankara
Investigational Site Number 804001, Kyiv
Lead Sponsor
Regeneron Pharmaceuticals
INDUSTRY
Sanofi
INDUSTRY